Agnes Colombani

Agnes Colombani has a diverse work experience in the pharmaceutical industry, starting with their current role as the Director of Pharmaceutical Development at MannKind Corporation since May 2022. Prior to this, they were the Director of Research at MannKind Corporation from April 2021 to May 2022. Before joining MannKind, Agnes worked as a Principal Scientist in Inhaled Medicines at Lupin Pharmaceuticals from May 2016 to April 2021. Agnes also had a similar role at Sandoz from February 2014 to March 2016. Agnes gained valuable experience in inhaled medicines during their time at AstraZeneca, where they worked as a Senior Scientist from May 2011 to February 2014. Agnes also held the position of Senior Scientist and R&T Leader in the Medicines Evaluation department at AstraZeneca from October 2007 to May 2011. Agnes started their career as a Post Doctoral Research Fellow at Pfizer from 2005 to 2007 and as a Research Assistant at the University of Liverpool from July 2001 to December 2001. Agnes also volunteered as a Research Assistant at the University of Cape Town from February 2000 to June 2000. Agnes began their professional journey as a Sales Engineer at Thermo Fisher Scientific from February 1999 to November 1999. Agnes'searliest role was as a Research Assistant at Universite Louis Pasteur from June 1997 to September 1998.

Agnes Colombani has a strong educational background in the field of science and engineering. Agnes began their education at Paris-Sud University (Paris XI) in 1992, where they pursued a DEUG A degree in Chemistry, Physics, and Math. From 1994 to 1997, they attended ECPM Ecole européenne de chimie polymères et matériaux de Strasbourg, where they earned their Ingenieur Chimiste degree in Physical Chemistry. Finally, they completed their academic journey at The University of Manchester from 2003 to 2005, obtaining a PhD in Chemical Engineering and Analytical Science.